CM
OCUL icon

Caption Management’s Ocular Therapeutix OCUL Stock Holding History

Caption Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$566K Sell
66,800
-548,300
-89% -$5.23M ﹤0.01% 1180
2025
Q4 		$7.47M Buy
615,100
+565,100
+1,130% +$6.86M 0.05% 407
2025
Q3 		$585K Hold
50,000
– – ﹤0.01% 1264
2025
Q2 		$464K Buy
+50,000
New +$391K 0.01% 1128
2021
Q1 		– Sell
-45,000
Closed -$933K – 1288
2020
Q4 		$933K Buy
+45,000
New +$668K 0.02% 624
2020
Q2 		– Sell
-50,000
Closed -$248K – 1129
2020
Q1 		$248K Buy
+50,000
New +$247K 0.01% 668
2019
Q4 		– Sell
-8,400
Closed -$26K – 952
2019
Q3 		$26K Buy
+8,400
New +$37.5K ﹤0.01% 665

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return